Literature DB >> 26663892

Structural and functional insights into enzymes of the vitamin K cycle.

J-K Tie1, D W Stafford1.   

Abstract

Vitamin K-dependent proteins require carboxylation of certain glutamates for their biological functions. The enzymes involved in the vitamin K-dependent carboxylation include: gamma-glutamyl carboxylase (GGCX), vitamin K epoxide reductase (VKOR) and an as-yet-unidentified vitamin K reductase (VKR). Due to the hydrophobicity of vitamin K, these enzymes are likely to be integral membrane proteins that reside in the endoplasmic reticulum. Therefore, structure-function studies on these enzymes have been challenging, and some of the results are notably controversial. Patients with naturally occurring mutations in these enzymes, who mainly exhibit bleeding disorders or are resistant to oral anticoagulant treatment, provide valuable information for the functional study of the vitamin K cycle enzymes. In this review, we discuss: (i) the discovery of the enzymatic activities and gene identifications of the vitamin K cycle enzymes; (ii) the identification of their functionally important regions and their active site residues; (iii) the membrane topology studies of GGCX and VKOR; and (iv) the controversial issues regarding the structure and function studies of these enzymes, particularly, the membrane topology, the role of the conserved cysteines and the mechanism of active site regeneration of VKOR. We also discuss the possibility that a paralogous protein of VKOR, VKOR-like 1 (VKORL1), is involved in the vitamin K cycle, and the importance of and possible approaches for identifying the unknown VKR. Overall, we describe the accomplishments and the remaining questions in regard to the structure and function studies of the enzymes in the vitamin K cycle.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  VKORC1 protein; gamma-glutamyl carboxylase; integral membrane proteins; vitamin K; vitamin K reductase

Mesh:

Substances:

Year:  2016        PMID: 26663892      PMCID: PMC5073812          DOI: 10.1111/jth.13217

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  98 in total

1.  A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors.

Authors:  B Brenner; B Sánchez-Vega; S M Wu; N Lanir; D W Stafford; J Solera
Journal:  Blood       Date:  1998-12-15       Impact factor: 22.113

2.  Genomic sequence and transcription start site for the human gamma-glutamyl carboxylase.

Authors:  S M Wu; D W Stafford; L D Frazier; Y Y Fu; K A High; K Chu; B Sanchez-Vega; J Solera
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

3.  Characterization of vitamin K-dependent carboxylase mutations that cause bleeding and nonbleeding disorders.

Authors:  Jian-Ke Tie; Jorge D A Carneiro; Da-Yun Jin; Ciro D Martinhago; Cees Vermeer; Darrel W Stafford
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

4.  The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin.

Authors:  G L Nelsestuen; T H Zytkovicz; J B Howard
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

5.  Surreptitious ingestion of coumarin anticoagulant drugs.

Authors:  R A O'Reilly; P M Aggeler
Journal:  Ann Intern Med       Date:  1966-05       Impact factor: 25.391

6.  The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif.

Authors:  Katrin J Czogalla; Arijit Biswas; Simone Rost; Matthias Watzka; Johannes Oldenburg
Journal:  Blood       Date:  2014-06-24       Impact factor: 22.113

7.  VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding.

Authors:  Gabriele Spohn; Andre Kleinridders; F Thomas Wunderlich; Matthias Watzka; Frank Zaucke; Katrin Blumbach; Christof Geisen; Erhard Seifried; Clemens Müller; Mats Paulsson; Jens C Brüning; Johannes Oldenburg
Journal:  Thromb Haemost       Date:  2009-06       Impact factor: 5.249

8.  Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.

Authors:  J J Lee; L M Principe; M J Fasco
Journal:  Biochemistry       Date:  1985-12-03       Impact factor: 3.162

Review 9.  The realm of vitamin K dependent proteins: shifting from coagulation toward calcification.

Authors:  Brecht A G Willems; Cees Vermeer; Chris P M Reutelingsperger; Leon J Schurgers
Journal:  Mol Nutr Food Res       Date:  2014-02-17       Impact factor: 5.914

10.  New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) - The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations.

Authors:  Benjamin Matagrin; Ahmed Hodroge; Adrien Montagut-Romans; Julie Andru; Isabelle Fourel; Stéphane Besse; Etienne Benoit; Virginie Lattard
Journal:  FEBS Open Bio       Date:  2013-02-16       Impact factor: 2.693

View more
  32 in total

1.  Warfarin, a juggler's demise.

Authors:  Laurent O Mosnier
Journal:  Blood       Date:  2018-06-21       Impact factor: 22.113

Review 2.  Therapeutic strategies for thrombosis: new targets and approaches.

Authors:  Nigel Mackman; Wolfgang Bergmeier; George A Stouffer; Jeffrey I Weitz
Journal:  Nat Rev Drug Discov       Date:  2020-03-04       Impact factor: 84.694

3.  Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey.

Authors:  Ahmet Kocael; Allison Pınar Eronat; Mete Bora Tüzüner; Ahmet Ekmekçi; Ahmet Lütfullah Orhan; İbrahim İkizceli; Hülya Yılmaz-Aydoğan; Oğuz Öztürk
Journal:  Mol Biol Rep       Date:  2019-02-02       Impact factor: 2.316

4.  Matrix Gla protein deficiency impairs nasal septum growth, causing midface hypoplasia.

Authors:  Juliana Marulanda; Hazem Eimar; Marc D McKee; Michelle Berkvens; Valentin Nelea; Hassem Roman; Teresa Borrás; Faleh Tamimi; Mathieu Ferron; Monzur Murshed
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

Review 5.  Reversing vitamin K antagonists: making the old new again.

Authors:  Sabine Eichinger
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 6.  Perioperative management of patients with atrial fibrillation receiving anticoagulant therapy.

Authors:  Takeshi Omae; Keito Koh; Masateru Kumemura; Sonoko Sakuraba; Yosuke Katsuda
Journal:  J Anesth       Date:  2019-05-08       Impact factor: 2.078

7.  Semi-empirical anticoagulation model (SAM): INR monitoring during Warfarin therapy.

Authors:  Marco Bontempi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-15       Impact factor: 2.745

8.  Naturally occurring UBIAD1 mutations differentially affect menaquinone biosynthesis and vitamin K-dependent carboxylation.

Authors:  Xuejie Chen; Natsuko Furukawa; Da-Yun Jin; Yizhou Liu; Darrel W Stafford; Craig M Williams; Yoshitomo Suhara; Jian-Ke Tie
Journal:  FEBS J       Date:  2021-12-01       Impact factor: 5.622

9.  Warfarin and vitamin K compete for binding to Phe55 in human VKOR.

Authors:  Katrin J Czogalla; Arijit Biswas; Klara Höning; Veit Hornung; Kerstin Liphardt; Matthias Watzka; Johannes Oldenburg
Journal:  Nat Struct Mol Biol       Date:  2016-12-12       Impact factor: 15.369

10.  Structural features determining the vitamin K epoxide reduction activity in the VKOR family of membrane oxidoreductases.

Authors:  Guomin Shen; Chaokun Li; Qing Cao; Abhin Kumar Megta; Shuang Li; Meng Gao; Hongli Liu; Yan Shen; Yixiang Chen; Haichuan Yu; Sanqiang Li; Weikai Li
Journal:  FEBS J       Date:  2022-02-10       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.